UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Flaviviruses are neurotropic, but how do they invade the CNS?

The Journal of infection, 2014-09, Vol.69 (3), p.203-215

Neal, J.W

2014

Volltextzugriff (PDF)

The role of primary infection of Schwann cells in the aetiology of infective inflammatory neuropathies

The Journal of infection, 2016-11, Vol.73 (5), p.402-418

2016

Volltextzugriff (PDF)

Corrigendum to “The role of primary infection of Schwann cells in the aetiology of infective inflammatory neuropathies” [J Infect 73 (2016) 402–418]

The Journal of infection, 2017-05, Vol.74 (5), p.525-525

2017

Volltextzugriff (PDF)

Innate Immunity and Protective Neuroinflammation: New Emphasis on the Role of Neuroimmune Regulatory Proteins

International Review of Neurobiology, 2007-01, Vol.82 (3), p.29-55

2007

Volltextzugriff (PDF)

Case Series of MET Exon 14 Skipping Mutation-positive Non–Small Cell Lung Cancers and Response to Crizotinib

International journal of radiation oncology, biology, physics, 2017-05, Vol.98 (1), p.239-239

2017

Volltextzugriff (PDF)

Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets

The Journal of infection, 2012-07, Vol.65 (1), p.1-16

2012

Volltextzugriff (PDF)

CAPP-Seq Circulating Tumor DNA Analysis for Early Detection of Tumor Progression After Definitive Radiation Therapy for Lung Cancer

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S41-S42

2016

Volltextzugriff (PDF)

Increased Complement Biosynthesis By Microglia and Complement Activation on Neurons in Huntington's Disease

Experimental neurology, 1999-10, Vol.159 (2), p.362-376

1999

Volltextzugriff (PDF)

Ultrasensitive Detection of Circulating Tumor DNA in Non-Small Cell Lung Cancer by Deep Sequencing

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S75-S75

2014

Volltextzugriff (PDF)

Circulating Tumor DNA Concentrations Reflect Metabolic Tumor Volume in NSCLC

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S812-S812

2014

Volltextzugriff (PDF)

Noninvasive and Ultrasensitive Quantitation of Circulating Tumor DNA by Hybrid Capture and Deep Sequencing

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S92-S92

2013

Volltextzugriff (PDF)

Handbook of Applied System Science

1, 2016

Volltextzugriff (PDF)

Randomized Phase 2 Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Single-Agent Chemotherapy in Previously Treated KRAS Mutant Advanced Non-Small Cell Lung Cancer (NSCLC)

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S36-S36

2014

Volltextzugriff (PDF)

MA02.06 Molecular Distribution of Patients with Non-Small Cell Lung Cancer Eligible for Lung Cancer Screening

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S102-S103

2023

Volltextzugriff (PDF)

CNS Control after First-Line Osimertinib in Patients with Metastatic EGFR-Mutant NSCLC

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e110-e110

2023

Volltextzugriff (PDF)

KRAS Mutation is Associated with Decreased Overall Survival after Thoracic Radiation Therapy in Patients with Locally Advanced Non-small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S36-S36

2010

Volltextzugriff (PDF)

P1.12A.10 Effect of De Novo Co-Mutations on Clinical Outcomes in Patients Receiving First-Line Osimertinib for EGFR-Mutated NSCLC

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S196-S197

2024

Volltextzugriff (PDF)

A Phase 2 Single-Arm Trial of High-Dose Radiotherapy Added to Immunotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.S60-S60

2024

Volltextzugriff (PDF)

1211P Indirect comparison of mobocertinib and standard of care in platinum-pretreated patients with NSCLC with EGFR exon 20 insertion

Annals of oncology, 2021-09, Vol.32, p.S964-S965

2021

Volltextzugriff (PDF)

EP16.02-015 Phenotyping Malignant Pleural Effusions with Mass Cytometry: Evidence of EMT and MET States in Late-Stage NSCLC

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S577-S578

2022

Volltextzugriff (PDF)

EP08.02-098 Phase 2 EVOKE-02 Study of Sacituzumab Govitecan and Pembrolizumab±Platinum in First-Line Metastatic NSCLC

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S448

2022

Volltextzugriff (PDF)

EP06.03-16 Demographic and Genomic Characteristics of Non-Small Cell Lung Cancer Patients with ARID1A Alterations

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S489

2023

Volltextzugriff (PDF)

MO01.01 Durvalumab for Patients with Stage III EGFR-Mutated Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy

Journal of thoracic oncology, 2021-01, Vol.16 (1), p.S15-S15

2021

Volltextzugriff (PDF)

OA17.06 Impact of Using Smoking Duration in Place of Pack-Years as Eligibility Criteria for Lung Cancer Screening to Reduce Racial and Ethnic Disparities

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S49-S49

2024

Volltextzugriff (PDF)

EP08.02-081 Cabozantinib Plus Atezolizumab in First or Second-Line Advanced NSCLC and Previously-Treated EGFR Mutant Advanced NSCLC

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S439

2022

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(206)
Mit Volltextzugriff
(200)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(218)

Erscheinungsjahr

n.n

Thema

Science & Technology
(105)
Life Sciences & Biomedicine
(76)
Biological And Medical Sciences
(48)
Fundamental And Applied Biological Sciences. Psychology
(33)
Animals
(29)
Humans
(26)
Physical Sciences
(25)
Physics
(21)
Male
(19)
Entomology
(18)
Neurosciences & Neurology
(16)
Exact Sciences And Technology
(15)
Medical Sciences
(15)
Middle Aged
(14)
Neurosciences
(14)
Female
(13)
High Energy Physics - Experiment
(13)
Invertebrates
(13)
Tingidae
(13)
Adult
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Flaviviruses are neurotropic, but how do they invade the CNS?

The role of primary infection of Schwann cells in the aetiology of infective inflammatory neuropathies

Corrigendum to “The role of primary infection of Schwann cells in the aetiology of infective inflammatory neuropathies” [J Infect 73 (2016) 402–418]

Innate Immunity and Protective Neuroinflammation: New Emphasis on the Role of Neuroimmune Regulatory Proteins

Case Series of MET Exon 14 Skipping Mutation-positive Non–Small Cell Lung Cancers and Response to Crizotinib

Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets

CAPP-Seq Circulating Tumor DNA Analysis for Early Detection of Tumor Progression After Definitive Radiation Therapy for Lung Cancer

Increased Complement Biosynthesis By Microglia and Complement Activation on Neurons in Huntington's Disease

Ultrasensitive Detection of Circulating Tumor DNA in Non-Small Cell Lung Cancer by Deep Sequencing

Circulating Tumor DNA Concentrations Reflect Metabolic Tumor Volume in NSCLC

Noninvasive and Ultrasensitive Quantitation of Circulating Tumor DNA by Hybrid Capture and Deep Sequencing

Handbook of Applied System Science

Randomized Phase 2 Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Single-Agent Chemotherapy in Previously Treated KRAS Mutant Advanced Non-Small Cell Lung Cancer (NSCLC)

MA02.06 Molecular Distribution of Patients with Non-Small Cell Lung Cancer Eligible for Lung Cancer Screening

CNS Control after First-Line Osimertinib in Patients with Metastatic EGFR-Mutant NSCLC

KRAS Mutation is Associated with Decreased Overall Survival after Thoracic Radiation Therapy in Patients with Locally Advanced Non-small Cell Lung Cancer

P1.12A.10 Effect of De Novo Co-Mutations on Clinical Outcomes in Patients Receiving First-Line Osimertinib for EGFR-Mutated NSCLC

A Phase 2 Single-Arm Trial of High-Dose Radiotherapy Added to Immunotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

1211P Indirect comparison of mobocertinib and standard of care in platinum-pretreated patients with NSCLC with EGFR exon 20 insertion

EP16.02-015 Phenotyping Malignant Pleural Effusions with Mass Cytometry: Evidence of EMT and MET States in Late-Stage NSCLC

EP08.02-098 Phase 2 EVOKE-02 Study of Sacituzumab Govitecan and Pembrolizumab±Platinum in First-Line Metastatic NSCLC

EP06.03-16 Demographic and Genomic Characteristics of Non-Small Cell Lung Cancer Patients with ARID1A Alterations

MO01.01 Durvalumab for Patients with Stage III EGFR-Mutated Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy

OA17.06 Impact of Using Smoking Duration in Place of Pack-Years as Eligibility Criteria for Lung Cancer Screening to Reduce Racial and Ethnic Disparities

EP08.02-081 Cabozantinib Plus Atezolizumab in First or Second-Line Advanced NSCLC and Previously-Treated EGFR Mutant Advanced NSCLC

Suchergebnisse filtern